Emergent BioSolutions applies for anthrax vaccine award Aug 2, 2008
Emergent recently received a federal grant from the National Institute of Allergy and Infectious Diseases for a five-year allotment for its next-generation anthrax treatment vaccine. Reader Comments. (Washington Business Journal, DC)
Black U.S. AIDS rates rival African nations' Jul 31, 2008
"Five percent of the entire population (in DC) is infected... that's comparable to countries like Uganda or South Africa," , director of the National Institute of Allergy and Infectious Diseases, told CNN for the recent "Black in America" documentary. According to this report, if black Americans made up their own country, it would rank above Ethiopia (420,000 to 1,300,000) and below Ivory Coast (750,000) in HIV population. (CNN -- Health)
Zapping microbes with lasers and enzymes Jul 29, 2008
I think its a great idea, said Frank DeLeo, acting chief of the Laboratory of Human Bacterial Pathogenesis at the National Institute of Allergy and Infectious Diseases Rocky Mountain Laboratories in Hamilton, Mont. DeLeo noted that other researchers have taken a similar approach with the photo-activated and FDA-approved dye methylene blue, which targets bacterial DNA. An increasing body of literature, he said, suggests that this general strategy could work well not only for MRSA but... (MSNBC -- Terrorism)
AIDS vaccine search in US makes major U-turn after letdowns Jul 28, 2008
Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), and his colleagues announced the turnabout in an article in the Science magazine, which released the item a day before its formal publication Friday. In an interview with DPA ahead of the embargoed publication, Fauci said that his federally fund 00004000 ed institute - which distributes about 80 percent of the money spent worldwide on vaccine research - would "rev up the burners" to tackle the... (Economic Times)
AIDS-Prevention Drug Trial for Breastfed Babies Splits Researchers on Use Jul 25, 2008
The U.S. National Institute of Allergy and Infectious Diseases and the Fogarty International Center also funded the study. To contact the reporter on this story: at. (Bloomberg -- Asia)
New Vaccine May Protect Against All Four Strains Of Dengue Virus Jul 24, 2008
19, 2003) Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with proteins. (Mar. (Science Daily)
Government to release revised US HIV estimates Jul 23, 2008
In June, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he believed the numbers had risen from 40,000 to 50,000 a year, although the CDC denied he had seen the new estimates. Late on Tuesday, the CDC said it would release the new estimates on August 3 in the Journal of the American Medical Association. (Scientific American)
US Cancels Major AIDS Vaccine Trial Jul 22, 2008
So, basically a vector is the vehicle that we (use to) try to deliver the elements of HIV (AIDS virus) to teach the immune system," he says. Warren says that this vaccine candidate also could not infect a person with HIV. "So, all of this caused a lot of extra analysis about the PAVE 100 trial," he says. Last Thursday, Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, decided to cancel it. Warren considers this "a very big point" in AIDS vaccine history but is... (Voice of America)
What's Next for the HIV Vaccine? Jul 20, 2008
On July 17, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, scrapped plans for a large clinical trial of the government's most advanced HIV vaccine candidate to date. The vaccine, a two-shot injection, was designed to fight HIV infection a new way by activating the body's cell-based immune responses rather than by relying on antibodies to HIV.. (TIME)
Booster Vaccination May Help With Possible Future Avian Influenza Pandemic Jul 19, 2008
(June 1, 2004) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two contracts to support the production and clinical testing of an. (Dec. (Science Daily)
1998: Syphilis Genome Sequenced; 2008: Syphilis on the Rise Jul 18, 2008
At the time, Penelope Hitchcock, the chief of the sexually transmitted disease branch of the National Institute of Allergy and Infectious Diseases (NIAID), hailed the work as critical to developing better drugs. NIAID director Anthony Fauci added the genome would boost efforts to develop a preventative vaccine. (Scientific American)
US scientists scrap major AIDS vaccine test Jul 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID), part of the government's National Institutes of Health, said after consulting scientists and advocacy groups it "has determined that it will not conduct the HIV vaccine study known as PAVE 100.". "However, NIAID believes the vaccine developed by its Vaccine Research Center (VRC) is scientifically intriguing and sufficiently different from previously tested HIV vaccines to consider testing it in a smaller, more focused clinical... (Sydney Morning Herald -- World)
Trial for Vaccine Against H.I.V. Is Canceled Jul 18, 2008
The official who canceled the government trial, Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said it was becoming clearer that more fundamental research and animal testing would be needed before an H.I.V. vaccine was ever marketed. Scientists say that developing a vaccine against H.I.V. is one of the most difficult scientific endeavors in history because of the uncanny nature of the virus. (Atlanta Journal-Constitution -- Health)
Gene Signatures For Scleroderma Discovered Jul 17, 2008
20, 1998) A National Institute of Allergy and Infectious Diseases (NIAID) grantee in Seattle has found experimental data to support a new hypothesis about the genesis of scleroderma, an autoimmune disorder. (Nov. (Science Daily)
Exhausted B Cells Hamper Immune Response To HIV Jul 15, 2008
Now, researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown that a similar type of exhaustion strikes another important brigade of immune system soldiers: the B cells that make virus-fighting proteins called antibodies. In most HIV-infected individuals not receiving antiretroviral therapy, the virus replicates continuously, causing systemic disturbances that include changes in certain subsets of B cells that... (Science Daily)
BAY AREA BIZ Jul 13, 2008
National Institute of Allergy and Infectious Diseases, United States and Japan Immunosenescence Workshop, Friday through July 21, Hyatt at Fisherman's Wharf. Chemical Producers ibutors Association, annual meeting, next Sunday through July 25, Argonaut Hotel. (San Francisco Chronicle -- Business)
New Hope against the Cold Sore Virus Jul 4, 2008
"This provides a new strategy to use for seeking a cure," said Christopher Beisel, a virologist and program officer at the U.S. National Institute of Allergy and Infectious Diseases, which funded the Duke research. "However, I always caution people that when something like this comes out, and people start talking about cures, that there's a long way to go, starting with animal experiments.". (MEDLINEplus)
Penn animal study identifies new DNA weapon against avian flu Jul 2, 2008
VGX Pharmaceuticals and the National Institute of Allergy and Infectious Diseases provided partial funding for this research. Dr. Weiner sits on the scientific advisory board of VGX, and collaborates with Wyeth, Merck, BMS, Althea, and Virxsys, as well as other companies on DNA vaccine technologies. (EurekAlert!)
The Buzz on Mosquito Protection Jul 1, 2008
Recent reports from the National Institute of Allergy and Infectious Diseases (NIAID) state that widespread appearance of Dengue Fever in the continental United States is a real possibility. The American Mosquito Control Association (AMCA) is an international organization of nearly 2,000 public health professionals dedicated to preserving health through safe, environmentally-sound mosquito control programs since 1935. (Sebastopol Sonoma West Publishing, CA)
Lyme Disease Bacterium Came From Europe Before Ice Age Jun 30, 2008
(June 21, 2001) A new test developed with funding from the National Institute of Allergy and Infectious Diseases (NIAID) has been shown to be highly accurate and sensitive for detecting antibodies to Lyme disease. (June 6, 2000) New research from scientists at the University of Georgia, just published in the journal Science, demonstrates that Borrelia burgdorferi, the bacterium that causes Lyme disease in humans, is the. (Science Daily)
Nintendo Numbing Jun 26, 2008
Besides Bubba, among the 250 headliners: Homeland Security Secretary Michael Chertoff; former Supreme Court Associate Justice Sandra Day O'Connor; Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases; National Endowment for the Arts Chairman Dana Gioia; Austan Goolsbee, economic adviser to soon-to-be-crowned Democratic presidential nominee Sen. Barack Obama; and Douglas Holtz-Eakin, policy adviser to the presumptive Republican presidential pick Sen. (Townhall.com)
Potential Role Of Fish-based Fatty Acids In Resolving, Preventing Asthma Jun 26, 2008
The research, supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, was led by a research team at Brigham and Women's Hospital and Harvard Medical School. Resolvin E1 (RvE1) is a metabolic product of an omega-3 fatty acid found in cold-water fish such as salmon, mackerel and anchovies. (Science Daily)
Exotic illnesses afflict American poor Jun 25, 2008
Dr. Lee Hall, chief of parasitology and international programs at the National Institute of Allergy and Infectious Diseases, said his agency funded research into the diseases, but primarily as global, not national, problems. "Do we need better data? We probably do, but that's probably true . . . for infectious diseases of the poor in general.". (Los Angeles Times)
SeraCare beats odds to rejoin Nasdaq Jun 21, 2008
7 million federal contract with the National Institute of Allergy and Infectious Diseases and sold its genomics unit in Cambridge for $2 million in cash, plus royalties. SeraCare emerged from bankruptcy in May 2007 with the same group of shareholders and a plan to repay its creditors in full. (Boston Globe)
Study: Herpes/HIV Correlation Wrong Jun 21, 2008
The study was paid for by the United States' National Institute of Allergy and Infectious Diseases, other U.S. government institutes, and by GlaxoSmithKline PLC, which sells aciclovir as Zovirax. A small study in Tanzania last year also suggested that treating herpes didn't help reducing HIV susceptibility. (Time.com)
President Bush Honors Presidential Medal of Freedom Recipients Jun 20, 2008
As the Director of the National Institute of Allergy and Infectious Diseases for more than 23 years, Tony Fauci has led the fight against HIV and AIDS. He was also a leading architect and champion of the Emergency Plan for AIDS Relief, which over the past five years has reached millions of people -- preventing HIV infections in infants and easing suffering and bringing dying communities back to life. The man who would lead the fight against this dreaded disease came from an Italian American... (White House News Releases)
Are HIV Prevention Gels Safe For Pregnant Women, Their Babies? Jun 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both components of the U.S. National Institutes of Health, are funding the study. Women, who represent nearly half of the 33. (Science Daily)
Ancient Antibody Molecule Offers Clues To How Humans Evolved Allergies Jun 15, 2008
14, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered how evolution may have lumbered humans with allergy problems. The team from the Randall Division of Cell & Molecular Biophysics, King's College London are working on a molecule vital to a chicken's immune system which represents the evolutionary ancestor of the human antibodies that cause allergic reactions. (Science Daily)
US fails to get number of AIDS cases below ideal level Jun 13, 2008
Addressing a press conference on Tuesday, Director of the National Institute of Allergy and Infectious Diseases Dr Anthony Fauci said more than 750,000 AIDS cases had been diagnosed and over 500,000 deaths had occurred in the US.. An important aspect of the problem is 40,000 to 52,000 new infections that occurred each year but that level had hit a plateau for the last 14 years, he added. (Daily News & Analysis)
Bush names Presidential Medal of Freedom winners Jun 12, 2008
An adviser to the government on global AIDS issues, he is the director of the National Institute of Allergy and Infectious Diseases. Dr. (Yahoo News -- Politics)
Peter Piot, Head of UN AIDS Agency, to Step Down After 13 Years Jun 11, 2008
Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, also called for more efforts to develop a safe and effective HIV vaccine after the failure of. s product last year, which he called the ``top candidate. (Bloomberg)
Weather, Stomach Bugs And Climate Change: Refining The Model Jun 5, 2008
This work was supported by the U.S. Environmental Protection Agency; the National Institute of Allergy and Infectious Diseases and the National Institute of Environmental Health Sciences, both institutes of the National Institutes of Health. Journal reference. (Science Daily)
Sars patients can provide therapy Jun 4, 2008
A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)
Protein Plays Key Role In Transmitting Deadly Malaria Parasite To Humans Jun 3, 2008
The study was supported by a grant from the National Institute of Allergy and Infectious Diseases. Other study authors were Dr. Bharath Balu, Jonah Smith and Sarita Mendonca. (Science Daily)
AIDS Vaccine, Similar to Merck's Failed Attempt, May Get Human Testing Jun 2, 2008
Government advisers voted 23 to 3 on May 30 in favor of the new study, and Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, said he would review their comments and decide ``reasonably soon'' whether to proceed. The government-developed vaccine has components similar to those in a shot made by that was terminated last year when 49 recipients became infected, compared with 33 people who got sham inoculations. (Bloomberg -- US)
New Target For Cancer Drugs? Gatekeepers Are Discovered In The Human Cell 'Shredder' May 28, 2008
20, 2000) Proteins that help clean and organize the inside of certain T cells may assist HIV in spreading through the body, scientists from the National Institute of Allergy and Infectious Diseases (NIAID). (Oct. (Science Daily)
How Common Vaccine Booster Works May 25, 2008
This research was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Journal reference. (Science Daily)
New Hope For HIV Vaccine: Unique HIV Vaccine Formula Elicits Strong Immune Responses May 24, 2008
In this phase I clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), volunteers first received three injections of a DNA vaccine which expresses protective antigens from the HIV virus, followed by two injections of a protein vaccine whose components matched those included in the DNA vaccine. The report in Vaccine is the first scientific article in which a DNA prime-protein boost combination vaccination method is tested in humans for HIV vaccine... (Science Daily)
Scientists discover how common vaccine booster works May 23, 2008
In an online paper in the journal Nature, Yale University researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, explain how a common ingredient in many vaccines stimulates and interacts with the immune system to help provide protection against infectious diseases. According to Eurekalert, the news service of the American Association for the Advancement of Science, vaccines must possess not only the bacterial or viral... (Hindu)
West Nile Vaccine Breakthrough May 22, 2008
ScienceDaily (May 21, 2008) University of Queensland researchers have made a giant leap forward in the race to develop a vaccine for the potentially debilitating West Nile virus. Associate Professor Alex Khromykh, from UQ's School of Molecular & Microbial Sciences, and colleagues have found a way to generate immune response levels comparable to a live virus vaccine, which could also help suffers of other disease such as dengue fever and Japanese encephalitis. (Science Daily)
New Latent TB Drug Saves Lives, Money May 20, 2008
The National Institute of Allergy and Infectious Diseases has more about. Copyright. (Health-Finder)
AIDS vaccine still out of reach May 18, 2008
"There are so many things we do not know in this field of HIV vaccines," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a summit his organization hosted in March to evaluate the situation going forward following the failure of the Merck vaccine. At the summit, leading AIDS specialists discussed avenues of research that remain largely unexplored, such as protection at the level of the mucous membranes, and the natural immunity of certain species of... (India Times, India -- Health/Science)
Most Effective Initial Therapy For HIV-1 Infection Identified May 17, 2008
D., and Lynne Peeples, M.S., Harvard School of Public Health; William Powderly, M.D., University College, Dublin, Ireland; Karin Klingman, M.D., National Institute of Allergy and Infectious Diseases, Division of AIDS.; Kevin Garren, Ph ... The study was conducted as part of the AIDS Clinical Trials Group with funding from the National Institute of Allergy and Infectious Diseases. (Science Daily)
Common Bacteria Activating Natural Killer T Cells May Cause Autoimmune Liver Disease May 17, 2008
The Taconic Emerging Models Program, supported by grants from the Merck genome Research Institute, the National Institute of Allergy and Infectious Diseases and JDRF, made available the mice used in the study. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection May 15, 2008
From the University of Pittsburgh, Pittsburgh (S.A.R., J.W.M.); the University of California, San Diego, San Diego (R.H.); the Harvard School of Public Health, Boston (A.G.D., L.P.); University College Dublin, Dublin (W.G.P.); the Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD (K.L.K.); Abbott Laboratories, Abbott Park, IL (K.W.G.); Bristol-Myers Squibb, Plainsboro, NJ (T.G.); Gilead Sciences, Foster City, CA (J.F.R.); Social and Scientific Systems, Silver... (New England Journal of Medicine)
Anthrax vaccine to be studied in Seattle May 13, 2008
The private, non-profit Benaroya Research Institute was awarded one of 14 grants in a $74 million program launched yesterday by the National Institute of Allergy and Infectious Diseases. The project aims to find better vaccines or drugs to protect against infectious diseases such as influenza, West Nile virus or bioterrorism agents such as anthrax. (Yahoo News -- Anthrax)
Bio-Rad, Sandia lab partner on toxin tests May 12, 2008
2 million, five-year grant from the National Institute of Allergy and Infectious Diseases for a biotoxin test they are developing. The goal is to design a small, portable and easy-to-use instrument to detect signs of such toxins in blood. (East Bay Business Times, CA)
New Agent Strikes At Most Common Cause Of Infant Hospitalization In U.S. May 8, 2008
This research was conducted under a subcontract to Garofalo from the National Institute of Allergy and Infectious Diseases Viral Respiratory Pathogens Research Unit. Adapted from materials provided by. (Science Daily)
Genvec wins third grant from NIH this year May 8, 2008
Gaithersburg-based Genvec Inc. (NASDAQ: GNVC) announced Wednesday that it has received a two-year, $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the. This is the third $600,000 NIH grant Genvec has secured in 2008. (Washington Business Journal, DC)
New agent strikes at respiratory syncytial virus replication May 6, 2008
This research was conducted under a subcontract to Garofalo from the National Institute of Allergy and Infectious Diseases Viral Respiratory Pathogens Research Unit. The University of Texas Medical Branch at Galveston Public Affairs Office 301 University Boulevard, Suite 3. (EurekAlert!)
New Ultrasensitive Assay Detects Most Poisonous Substance Known May 3, 2008
Funding to develop the new assay was provided by the National Institute of Allergy and Infectious Diseases through its biodefense network partner the Pacific South West Regional Center of Excellence. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
New Vaccine Against Deadly Bird Flu Apr 20, 2008
National Institute of Allergy and Infectious Diseases and the CDC's National Center for Infectious Diseases and National Vaccine Program provided funding for the study. The other researchers involved with The Journal of Infectious Diseases study were paper co-lead researcher Mary Hoelscher, postdoctoral researcher Sanjay Garg, research scientists Vic Veguilla and Yumi Matsuoka, and principal investigators Jacqueline Katz and Ruben Donis, all of the CDC; and co-lead researcher Neetu Singh,... (Science Daily)
Air Pollution Affects Respiratory Health In Children With Asthma, Study Shows Apr 18, 2008
Using data collected from the National Institute of Allergy and Infectious Diseases (NIAID) Inner-City Asthma Study (ICAS), researchers examined 861 children with persistent asthma, aged 5 to 12 years, living in low-income areas in seven U.S. inner-city communities: Boston, the Bronx, Chicago, Dallas, New York City, Seattle and Tucson ... The study was funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Environmental Health Sciences (NIEHS), and... (Science Daily)
Researchers chart how new flu strains travel Apr 17, 2008
The group charged with making the decisions about vaccines has been right about 80% of the time, said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, and the new findings should lead to an even higher success rate. "If we have competing candidates, this will help to pick which virus should go in a vaccine," added Dr. Arnold S. Monto, an epidemiologist and flu specialist at the University of Michigan. (Los Angeles Times)
Leading HIV researchers to collaborate on vaccine development Apr 16, 2008
Established in 2005 by the National Institute of Allergy and Infectious Diseases, CHAVI, headquartered at Duke University, is an international consortium of 70 investigators at 37 institutions working to overcome major roadblocks in HIV vaccine development. The International AIDS Vaccine Initiative is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. (EurekAlert! -- Business News)
Researchers join forces for AIDS vaccine Apr 16, 2008
CHAVI, established in 2005 by the National Institute of Allergy and Infectious Diseases, is based at Duke University, but includes a consortium of 70 investigators at 37 institutions, including UNC-Chapel Hill. Its mission was to bring leading AIDS researchers under a single organization, to share research findings and focus on specific areas of inquiry. (News & Observer)
Boston Trial to Test New HIV/AIDS Vaccine Apr 13, 2008
The rAd26 vaccine was developed by the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program, sponsored by the U.S. National Institute of Allergy and Infectious Diseases. The program brings together academic and industry researchers to accelerate development of promising HIV/AIDS vaccine candidates. (Health-Finder)
Nose Spray Anthrax Vaccine Effective In Tests Apr 12, 2008
D., acting lab chief at the Laboratory of Bacterial Diseases within the National institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Although first assembled a decade ago, no one had yet looked at whether it would make a good component for a candidate anthrax vaccine. (Science Daily)
Cells on path to becoming mature T-cells more flexible than commonly thought Apr 10, 2008
This work was supported by grants from the National Institute of Allergy and Infectious Diseases, the Leukemia and Lymphoma Society, and an Institutional Training Grant from the National Cancer Institute. PENN Medicine is a $3. (EurekAlert!)
Probable Case of Human-to-Human Bird Flu Transmission Reported Apr 8, 2008
(SOURCES: Anthony S. Fauci, M.D. director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md ... Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which funded the study, said, "This is not something new. Limited human-to-human transmission has been seen intermittently for years and years. This is just another example among a few. It's what we call a dead-end person-to-person transmission.". (Health-Finder)
Lingering Bacteria Don't Indicate Chronic Lyme Disease Apr 3, 2008
Funding for this study was provided by a U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases. Adapted from materials provided by. (Science Daily)
Genvec wins $600,000 grant Apr 3, 2008
Genvec, which is also working on vaccines to fight cancer, flu and genital herpes, said the money is a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases of NIH. The two-year grant will be used to develop enhancements to Genvec's adenovector technology for vaccine applications against malaria. "In addition to advancing our malaria vaccine program, work under this grant may provide improvements to our technology that could be applied... (Washington Business Journal, DC)
Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa Mar 27, 2008
The study was funded by the National Institute of Allergy and Infectious Diseases and the Doris Duke Charitable Foundation. Study co-authors are Mariam Fofana, Nomita Divi, Bingxia Wang, and Kenneth Freedberg of the MGH; Robin Wood, University of Cape Town, South Africa; Milton Weinstein and Sue Goldie, Harvard School of Public Health; Neil Martinson, Johns Hopkins University; Elena Losina, Brigham and Womens Hospital; Yazdan Yazdanpanah, Laboratory of Economic and Social Research, Lille,... (EurekAlert!)
Government to overhaul AIDS vaccine effort Mar 26, 2008
"We need to turn the nob in the direction of discovery. That is unambiguous," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who convened the meeting outside of Washington. advertisement. (MSNBC -- Health)
New Triple-threat Weapon Needed In War Between Man And Microbe Mar 26, 2008
(Credit: Courtesy of National Institute of Allergy and Infectious Diseases of the NIH). Related Stories. (Science Daily)
